After-Hours Gainers: Biotech and Med-Tech Stocks Surge on FDA Signals, Clinical Data, and Merger News

Several biotech and med-tech stocks surged in Monday's after-hours session, driven by regulatory progress, clinical-data visibility, and merger-related developments. Organogenesis Holdings (ORGO) rose over 11% after completing a planned Type-B meeting with the FDA, while IO Biotech (IOBT) edged higher on published trial data. STAAR Surgical (STAA) climbed over 4% after Institutional Shareholder Services revised its stance on the company's pending merger with Alcon. ClearPoint Neuro (CLPT) and EUDA Health (EUDA) also gained over 9% despite no company-specific news.